The Role of Chlamydia trachomatis Polymorphic Membrane Proteins in Inflammation and Sequelae among Women with Pelvic Inflammatory Disease
Table 3
Frequency of baseline inflammatory markers and reproductive sequelae by PmpD antibody expression.
Inflammation and sequelae
PmpD
No
Yes
value
Inflammation
aElevated temperature (>100.4°F)
0 (0.0)
1 (3.7)
0.7500
aElevated WBC count (>10,000 mm3)
2 (20.0)
8 (27.6)
0.3038
Erythrocyte sedimentation rate (>15 mm/hr)
3 (30.0)
10 (33.3)
0.2996
aC-reactive protein (>5 mg/dL)
2 (40.0)
6 (54.6)
0.3590
Bilateral adnexal tenderness
7 (70.0)
25 (83.3)
0.2224
aMucopurulent cervicitis
4 (50.0)
19 (70.4)
0.1862
Upper genital tract infection
4 (50.0)
17 (70.8)
0.1878
aEndometritis
3 (33.3)
15 (55.6)
0.1609
Reproductive sequelae
Infertility
1 (10.0)
4 (13.3)
0.4165
bLive birth
7 (77.8)
13 (65.0)
0.2787
Pregnancy
8 (80.0)
24 (80.0)
1.000
bChronic pelvic pain
4 (44.4)
9 (30.0)
0.2219
bRecurrent PID
2 (22.2)
4 (13.3)
0.3024
aWBC data was available for 39 patients, CRP data was available for 16 patients, mucopurulent cervicitis data was available for 35 patients, UGTI data was available for 36 patients, and endometritis data was available for 32 patients; b live birth data was available for 29 patients; chronic pelvic pain and recurrent PID data were available for 39 patients.
